Surge in Women’s Testosterone Prescriptions Clashes with Pharmacy Dispensing Barriers
Prescriptions for testosterone among women have nearly tripled since 2023, yet many face delays and denials at major pharmacies due to the lack of a U.S.-approved product for this demographic. Clinicians are increasingly using the hormone off-label for menopause symptoms, but medical societies support its use only for low sexual desire. The FDA is set to review evidence on Thursday, while patients struggle with high costs and complex dosing requirements.